X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/startups-raised-millions-to-in-license-drugs-to-china-then-the-model-fell-apart/
https://www.globenewswire.com//news-release/2024/02/28/2836811/0/en/LianBio-Announces-Voluntarily-Delisting-from-Nasdaq.html
https://www.fiercebiotech.com/biotech/lianbio-lays-half-workforce-biotech-begins-wind-down
https://www.globenewswire.com/news-release/2023/12/26/2801026/0/en/Nanobiotix-Partner-LianBio-Assigns-Its-Development-and-Commercialization-Rights-for-NBTXR3-in-China-and-Other-Asian-Markets.html
https://www.globenewswire.com//news-release/2023/12/20/2799205/0/en/LianBio-Announces-Departure-of-Chief-Financial-Officer.html
https://www.globenewswire.com//news-release/2023/12/19/2798888/0/en/LianBio-Announces-Departure-of-Chief-Executive-Officer.html
https://www.globenewswire.com/news-release/2023/12/06/2792097/0/en/LianBio-s-Board-of-Directors-Unanimously-Determines-not-to-Pursue-Unsolicited-Proposal-from-Concentra-Biosciences.html
https://www.fiercebiotech.com/biotech/tang-capitals-concentra-back-another-buyout-offer-time-lianbio
https://www.globenewswire.com//news-release/2023/12/01/2789531/0/en/LianBio-Confirms-Receipt-of-Unsolicited-Proposal-from-Concentra-Biosciences.html
https://www.globenewswire.com//news-release/2023/11/13/2779430/0/en/LianBio-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Corporate-Update.html
Market Place
Share 
